andes virus DNA vaccine (NIAID/The Geneva Foundation)

N/A

Report date: 2025/10/28 17:51:07

Base Information

Drug Nameandes virus DNA vaccine (NIAID/The Geneva Foundation)
Drug Alias Nameandes virus DNA vaccine (USAMRIID)opt2 plasmid vaccine (NIAID/The Geneva Foundation)pWRG/AND-M vaccinepWRG/AND-M plasmid vaccine (NIAID/The Geneva Foundation)ANDV M gene containing pWRG7077 plasmid (NIAID/The Geneva Foundation)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHantavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUS Army Medical Research Institute of Infectious Diseases
China Registration ClassN/A

Develop Information

Active CompaniesThe Geneva FoundationNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsHantavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A